» Articles » PMID: 7544915

TRAF2-mediated Activation of NF-kappa B by TNF Receptor 2 and CD40

Overview
Journal Science
Specialty Science
Date 1995 Sep 8
PMID 7544915
Citations 300
Authors
Affiliations
Soon will be listed here.
Abstract

TNF receptor-associated factor (TRAF) proteins are candidate signal transducers that associate with the cytoplasmic domains of members of the tumor necrosis factor (TNF) receptor superfamily. The role of TRAFs in the TNF-R2 and CD40 signal transduction pathways, which result in the activation of transcription factor NF-kappa B, was investigated. Overexpression of TRAF2, but not TRAF1 or TRAF3, was sufficient to induce NF-kappa B activation. A truncated derivative of TRAF2 lacking an amino-terminal RING finger domain was a dominant-negative inhibitor of NF-kappa B activation mediated by TNF-R2 and CD40. Thus, TRAF2 is a common mediator of TNF-R2 and CD40 signaling.

Citing Articles

Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts.

Zhao W, Li J, Su T, Wang C, Fu Y, Li C J Inflamm Res. 2025; 18:3201-3213.

PMID: 40059949 PMC: 11890017. DOI: 10.2147/JIR.S507269.


NF-κB signaling is the major inflammatory pathway for inducing insulin resistance.

Mobeen A, Joshi S, Fatima F, Bhargav A, Arif Y, Faruq M 3 Biotech. 2025; 15(2):47.

PMID: 39845928 PMC: 11747027. DOI: 10.1007/s13205-024-04202-4.


Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer.

Deng Z, Li L, Meng Z, Zeng G, Cao R, Liu R BMC Cancer. 2025; 25(1):100.

PMID: 39825223 PMC: 11740393. DOI: 10.1186/s12885-025-13479-4.


Cimicifugin, a broad-spectrum inhibitor of and CDK7.

Kar P, Araveti P, Saxena K, Borah A, Sijwali P, Srivastava A Antimicrob Agents Chemother. 2024; 68(8):e0044024.

PMID: 39023263 PMC: 11304743. DOI: 10.1128/aac.00440-24.


Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid-derived suppressor cells by instigating apolarity during ageing.

Wang M, Han Y, Yao X, Duan X, Wan J, Lou X MedComm (2020). 2024; 5(6):e605.

PMID: 38868328 PMC: 11167233. DOI: 10.1002/mco2.605.